Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Rohto Pharmaceutical (4527)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,761.0 +39.5    +1.45%
31/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3982400008 
  • Volume: 789,400
  • Bid/Ask: 2,799.5 / 2,800.0
  • Day's Range: 2,724.0 - 2,765.0
Rohto Pharmaceutical 2,761.0 +39.5 +1.45%

4527 Balance Sheet

 
Featured here, the Balance Sheet for Rohto Pharmaceutical, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 214759 214196 207744 196136
Cash and Short Term Investments 89210 81877 79341 78080
Cash - - - -
Cash & Equivalents 86562 81877 79341 78080
Short Term Investments 2648 - 2371 -
Total Receivables, Net 69115 73004 68329 59758
Accounts Receivables - Trade, Net 44336 73004 68329 59758
Total Inventory 46657 48496 48585 46554
Prepaid Expenses - - - -
Other Current Assets, Total 9777 10819 11489 11744
Total Assets 346175 342160 334957 318871
Property/Plant/Equipment, Total - Net 68607 68392 68356 66681
Property/Plant/Equipment, Total - Gross 182408 - - -
Accumulated Depreciation, Total -113801 - - -
Goodwill, Net 2285 2276 2372 2468
Intangibles, Net 6931 6851 6957 6999
Long Term Investments 37329 50443 49526 46586
Note Receivable - Long Term 24779 23747 23583 -
Other Long Term Assets, Total 6405 2 2 1
Other Assets, Total -174 -13689 -8255 -1460
Total Current Liabilities 87087 83633 82966 79138
Accounts Payable 16991 22415 22852 23701
Payable/Accrued - - - -
Accrued Expenses 27292 22786 23063 22284
Notes Payable/Short Term Debt 5304 4359 4171 4163
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 37500 34073 32880 28990
Total Liabilities 99142 96150 96159 92872
Total Long Term Debt 5190 5273 5823 6943
Long Term Debt 5190 5273 5823 6943
Capital Lease Obligations - - - -
Deferred Income Tax 1597 - - -
Minority Interest 710 5973 5859 5703
Other Liabilities, Total -746 -12727 -12299 -3075
Total Equity 247033 246010 238798 225999
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 6504 6504 6504 6504
Additional Paid-In Capital 4516 5292 5292 5292
Retained Earnings (Accumulated Deficit) 209399 204620 197794 190290
Treasury Stock - Common -4939 -4938 -4938 -4938
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 31553 34532 34146 28851
Total Liabilities & Shareholders' Equity 346175 342160 334957 318871
Total Common Shares Outstanding 228.14 228.14 228.14 228.14
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4527 Comments

Write your thoughts about Rohto Pharmaceutical
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email